Bitcoin price upside momentum is gaining traction as a break above $12,500 serves as an upside catalyst. Considering that the price growth is accompanied by increased trading volumes, one might suggest that the trend will gain traction.
Facebook’s Libra project is drawing scrutiny from global regulators soon after the announcement last week. After the US, European regulators have asked the company to furnish more details about its cryptocurrency plans.
Requiring developers to consistently worry about security vulnerabilities takes them away from focusing on improving UX and other aspects of blockchain-based apps. Here comes ArpaChain, a project offering confluence of security, privacy, and better UX
The award-winning Opera Touch browser for iOS now features crypto wallet integration and Web 3 support. This completes Opera’s efforts to offer Web 3-ready browsers with built-in Crypto Wallet on Android, Windows, Mac, Linux and now iOS.
Just recently, a digital asset IRA (Individual Retirement Account) company called Bitcoin IRA, released the first ever self-directed cryptocurrency IRA. This achievement was created through a partnership with BitGo Trust.
In another win for OKLink, the sister company of the world’s second biggest cryptocurrency exchange by volume, Malta-based OKEx, launched today its Bitcoin Block Explorer platform, with the promise it was looking to offer similar explorers for other popular digital assets.
Kraken completed its crowdfunding round with $13,5 million raised. That way, Kraken pushed the company valuation towards $4 billion.
With the latest trend in decentralized technology, cryptocurrency experts consider an absolute endorsement of the digital tokens by online gambling site in the near future.
Facebook’s Libra cryptocurrency gets backing from a high-ranking entity, Fitch, with the credit rating agency stating that Libra is more secure compared to the other existing virtual currencies.
JPMorgan Chase is to going to initiate trials of its JPM Coin cryptocurrency with its corporate clients. The names of the companies involved in the upcoming trials are not revealed.